Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses



Michael, BD ORCID: 0000-0002-8693-8926, Dunai, C ORCID: 0000-0001-5799-2387, Needham, EJ ORCID: 0000-0001-7042-7462, Tharmaratnam, K ORCID: 0000-0002-8255-9822, Williams, R ORCID: 0009-0000-9505-9563, Huang, Y ORCID: 0000-0001-7843-9126, Boardman, SA ORCID: 0000-0003-4385-6004, Clark, JJ, Sharma, P ORCID: 0000-0002-9090-7540, Subramaniam, K
et al (show 88 more authors) (2023) Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses Nature Communications, 14 (1). 8487-. ISSN 2041-1723, 2041-1723

Access the full-text of this item by clicking on the Open Access link.

Abstract

To understand neurological complications of COVID-19 better both acutely and for recovery, we measured markers of brain injury, inflammatory mediators, and autoantibodies in 203 hospitalised participants; 111 with acute sera (1–11 days post-admission) and 92 convalescent sera (56 with COVID-19-associated neurological diagnoses). Here we show that compared to 60 uninfected controls, tTau, GFAP, NfL, and UCH-L1 are increased with COVID-19 infection at acute timepoints and NfL and GFAP are significantly higher in participants with neurological complications. Inflammatory mediators (IL-6, IL-12p40, HGF, M-CSF, CCL2, and IL-1RA) are associated with both altered consciousness and markers of brain injury. Autoantibodies are more common in COVID-19 than controls and some (including against MYL7, UCH-L1, and GRIN3B) are more frequent with altered consciousness. Additionally, convalescent participants with neurological complications show elevated GFAP and NfL, unrelated to attenuated systemic inflammatory mediators and to autoantibody responses. Overall, neurological complications of COVID-19 are associated with evidence of neuroglial injury in both acute and late disease and these correlate with dysregulated innate and adaptive immune responses acutely.

Item Type: Article
Uncontrolled Keywords: ISARIC4C Investigators, COVID-CNS Consortium, Humans, Brain Injuries, Glial Fibrillary Acidic Protein, Inflammation Mediators, Autoantibodies, Cytokines, Follow-Up Studies, Biomarkers, COVID-19, COVID-19 Serotherapy
Divisions: Faculty of Health & Life Sciences
Faculty of Health & Life Sciences > Inst. Infection, Vet & Ecological Sciences
Faculty of Health & Life Sciences > Inst. Population Health
Faculty of Health & Life Sciences > Inst. Systems, Molec & Integrative Biology > Inst. Systems, Molec & Integrative Biology
Faculty of Health & Life Sciences > Tech, Infrastructure & Env Directorate
Depositing User: Symplectic Admin
Date Deposited: 02 Jan 2024 15:41
Last Modified: 22 Jan 2026 08:42
DOI: 10.1038/s41467-023-42320-4
Open Access URL: https://www.nature.com/articles/s41467-023-42320-4
Related Websites:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3177687
Disclaimer: The University of Liverpool is not responsible for content contained on other websites from links within repository metadata. Please contact us if you notice anything that appears incorrect or inappropriate.